Abstract
INTRODUCTION
The world is confronted by the reality of large-scale counterfeit production of almost every conceivable drug [1, 2] . It is not surprising then that drugs are produced in gross violation of good manufacturing practices (GMP) and in utter disregard of pharmacopoeia standards [2, 3] . It is, therefore, desirable that deliberate and fraudulent labeling of drugs with respect to identity should be detected along the distribution chain as part of normal quality assurance processes [4] . There is the need to make available useful methods for accurately validating the authenticity and identity of available medications. This is in view of the fact that the greatest health risk faced by people of the world today is the lack of appropriate medicines for treating both common and life-threatening illnesses [4, 5] . The dangers posed by counterfeit products to public health in Nigeria have resulted in control measures by the Agency for Food and Drug Administration and Control (NAFDAC) such as daily enlightenment campaigns in the media [6, 7] . A way to complement NAFDAC's efforts against counterfeit drugs is to develop a simple and rapid method of identifying fake products [8] . The growing challenge is halting the distribution and marketing of such medicines at every level of the distribution chain [9, 10] . Equipment with multi-component profiling for the screening of chemicals have been documented in literature but their high cost often render unaffordable to several stakeholder along the distribution chain in several developing countries [11, 12] . Furthermore, such equipment requires technical handling and maintenance that are beyond the capacity of those in the distribution chain [13] . A Fast Chemical Identification System (FCIS), as has been used in China since 2005, needs to be developed and compiled for the use of pharmacists and other stakeholders to include drugs such as anti-infective drugs, analgesics, cardiovascular agents, etc. FCIS is usually targeted at the molecular structure and functional groups in the drug molecule [14] [15] [16] .
The 5-nitroimidazole compounds are widely used intestinal and extra-intestinal amoebicide. There has been documented evidence of the efficacy of the 5-nitroimidazoles on the causative organism, Entamoeba histolytica [17] . The increase in cases of amoebiasis is said to be traceable to counterfeiting [18] [19] [20] . The 5-nitroimidazoles most commonly found in the Nigerian market are metronidazole, tinidazole and secnidazole (Fig 1) . 
Preparation of test solution and crystals
Tablets of each of the drugs were crushed in a mortar and reduced into fine powder, and 1 g of the powder was shaken thoroughly in 100 ml of acetone in a conical flask. The drug was extracted into acetone and filtered with a filter paper. The filtrate (50 ml) was allowed to stand at room temperature for 15min to evaporate, yielding crystals. To 50 mg of the crystals of each drug was added zinc dust (50 mg) and 5ml 1M hydrochloric acid in a beaker in a boiling water bath for 5 min. The beaker was removed and then left to stand at room temperature for 20 min. The resulting product was dissolved in 50ml acetone at 50 o C in a water bath and filtered hot. The filtrate was again allowed to stand for 10 min at room temperature to allow the solvent to evaporate, leaving crystals. An amount of the crystals (20 mg) was dissolved in 10 ml chloroform to form the test solution. Similarly, 20mg of paracetamol powder was dissolved in 10ml acetone to form the test solution for paracetamol.
Colour reactions
Nitric acid reaction: To 1ml of the test solution was added three drops of 2M nitric acid. One drop of sodium hydroxide (40 %w/v) was added after 2 min. Sodium nitrite reaction: 1 g of sodium nitrite and 1 ml of 2M sulphuric acid were mixed in a test tube and cooled in ice. To 1 ml of the test solution was added one drop of the sodium nitrite reagent.
Bismuth subnitrate reaction:
Bismuth subnitrate (20 mg) was dissolved in 3 ml of 2M hydrochloric acid. This was diluted with water to 10 ml, 10 g of potassium iodide was added. This reagent (2 ml) was added to 1 ml of the test solution.
TLC identification
Thin layer identification (TLC) identification was carried out on a GF 254 plate (5cm x 10cm). Mobile phase A consisted of acetone, ethyl acetate and ammonia (100:5:1, v/v) while phase B consisted of acetone, chloroform and ammonia (100:15:1, v/v). Crystals obtained from the similarly treated drug products were dissolved in acetone to give a reference solution of 10 mg/ml. Two 
RESULTS
The results of the colour reactions for the various product brands are outlined in Tables  2 -4 along with R f values. The colours observed for the generic metronidazole, i.e., M A and M B , were similar for each of the reagent/test employed. Nitric acid test was not substituent-specific as orange colour was produced irrespective of the generic type of the nitroimidazole used. Sodium nitrite and bismuth subnitrate distinguished between metronidazole and the other two products as it gave a different colour. 
DISCUSSION

Colour reactions
Concentrated nitric acid, when employed with concentrated sulphuric acid, is used to indicate the aromatic character of a substance. A yellow colour is usually produced when 10% w/v sodium hydroxide is added to a substance with aromatic character, turning orange with excess alkali. The aminoimidazole formed by the zinc/hydrochloric acid reaction during the preparation of the test solution was reconverted via oxidation to nitroimidazole by nitration. Hence, reaction with concentrated nitric acid gave the expected result due to the aromatic nature of 5-nitroimidazoles, as the addition of 40 %w/v sodium hydroxide provided the excess alkali required to produce an orange colour which results from the formation of an aromatic nitro compound. All the brands of 5-nitroimidazole tested in our experiments gave an orange colour in the nitric acid test (Table 1) . A drug that could be fraudulently labelled as an anti-infective is paracetamol due to its low cost and mild antipyretic effect [21] . It has been noted that some labelled anti-infectives only reduce symptoms of illnesses for a while. The colour observed was brown for metronidazole brands, M A and M B , in sodium nitrite and bismuth subnitrate tests. Concentrated sulphuric acid reduced the nitro compound to the amino derivative as the sodium nitrite subsequently formed a diazotization derivative with the observed colour based on the extent of conjugation. Sodium nitrite in acidic medium forms diazonium salts with compounds bearing free amino group. The alkyl substituent on the imidazolyl nitrogen distinguishes the 5-nitroimidazole by the characteristic colours observed in sodium nitrate and bismuth subnitrate tests. The alkyl substitution on metronidazole is ethyl alcohol (a primary alcohol) which confers a brown colouration on the compound while tinidazole which bears ethyl sulphone gives a red colouration with the reagents.
The Nsubstitution on secnidazole is a secondary alcohol and this confers a red colour deeper in intensity than observed for tinidazole. The attached substituents on any system containing delocalized electrons either withdraw from the ring or donate electrons to it to a more or lesser extent. The colours, therefore, produced by such compounds depends on the availability and density of available electrons which affect the absorption and transmission of light.
TLC Methods A and B
The mobile phases A and B were designed to make a distinction between the 5-nitromidazole compounds. In the TLC systems, metronidazole and secnidazole were differentiated from tinidazole by reason of their R f values. The R f values of metronidazole brands,M A and M B in the various laboratories were similar. A similar finding was observed for the brands of tinidazole, T A and T B . The R f values of the brands of tinidazole were higher than those of metronidazole and secnidazole in the solvent systems (seeTable 4). This is probably due to its ethylsulphone substitution as against the primary and secondary alcohol functional group affiliations of metronidazole and secnidazole, respectively.
The spots produced with solvent system B were more conspicuous on exposure to iodine vapour in the tank. The movement of the solutes was also freer as indicated by R f values. While the spots for the brands of metronidazole and secnidazole were distinct, the ones for tinidazole exhibited tailing and had a lower R f ( Table 4) .
Influence of some variables on the method
The TLC experiments were conducted in laboratories situated in the three major geographic regions of Nigeria spanninging 25 -60 % relative humidity and a temperature range of 25 -35 o C. These tests were performed in different regions in order to determine if differences in temperature and humidity across the country would influence the tests. Although R f values were not highly reproducible, the relative pattern of appearance of the spots in the chromatograms was constant and, therefore, useful for drug identification.
Identification system
An identification system for the detection and screening of 5-nitroimidazole preparation was established by combining both the colour reaction and TLC tests. The identification system was rapid (Fig 2) and thus suitable for screening the 5 -nitroimidazole drugs tested in this work. However, since fraudulent labelling and other substandard features (e.g., excess or shortfall in the content of active ingredient in the formulation) often characterise unacceptable products, this identification system does not in any way obviate the need for quantitative evaluation of this group of drugs. 
CONCLUSION
The developed identification system based on colours produced by chemical interaction of reagents with the functional groups present in the molecule of 5 -nitroimidazole drugs, and TLC methods can be jointly used to identify fake drugs that are fraudulently labelled as 5-nitroimidazole. This identification system should be useful to those involved in drug distribution, especially community pharmacies and pharmacy departments of hospitals since it will afford them a qualitative assessment of the products. It should, however, be emphasized that the tests evaluated do not eliminate the need for quantitative assessment of this group of drugs as may be necessary.
